Status:
UNKNOWN
Tailored Information About the Coronavirus for Patients With Chronic Kidney Disease
Lead Sponsor:
Ivar Anders Eide
Conditions:
Renal Insufficiency, Chronic
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Randomized clinical trial focusing on the effect of tailored information on Covid-19 for patients with chronic kidney disease stage 5 on health literacy, anxiety and self-perceived health.
Detailed Description
This single-center randomized open clinical trial in persons with chronic kidney disease stage 5 investigates the effect of information about coronavirus targeted at the study population, using study ...
Eligibility Criteria
Inclusion
- Chronic kidney disease stage 5
Exclusion
- Covid-19 during last 12 months. Dementia or other reason why cannot participate like major depression, psychosis or hospitalized persons with severe frailty.
Key Trial Info
Start Date :
April 14 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2023
Estimated Enrollment :
215 Patients enrolled
Trial Details
Trial ID
NCT04854382
Start Date
April 14 2021
End Date
December 31 2023
Last Update
March 29 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Akershus University Hospital
Lørenskog, Akershus, Norway, 1478